订阅小程序
旧版功能

Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 Plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.

Nai-Jung Chiang,Kien Thiam Tan,Li-Yuan Bai,Chin-Fu Hsiao,Chung-Yu Huang,Yi-Ping Hung,Chien-Jui Huang,San-Chi Chen,Yan-Shen Shan,Yee Chao,Yi-Hsiang Huang,I-Cheng Lee,Pei-Chang Lee,Yung-Yeh Su,Shu-Jen Chen,Chun-Nan Yeh,Li-Tzong Chen,Ming-Huang Chen

Clinical Cancer Research（2022）

引用 9|浏览29
关键词
Gemcitabine,Biliary Tract Cancer,Neoadjuvant Therapy,N-terminal Acetylation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要